NANOLOGICA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.62 SEK | +2.18% |
|
+1.81% | -45.96% |
| Apr. 26 | Nanologica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 11 | Nanologica's New COO to Take Office in May | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)âs drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.
Sector
Commodity Chemicals
Calendar
2024-07-04
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -45.96% | 22.19M | |
| -25.15% | 20.6B | |
| -14.52% | 13.21B | |
| -9.17% | 9.69B | |
| -13.48% | 9.66B | |
| +9.07% | 6.61B | |
| +3.01% | 6.42B | |
| -30.31% | 5.29B | |
| -21.00% | 3.3B | |
| -34.73% | 3.06B |
- Stock Market
- Equities
- NICA Stock
- News Nanologica AB
- Nanologica Bags Additional Silica Supply Order in China
